Showing results (51-60 of 104) with videos related to
Sort By:
Pageof 11
The Pediatric Infectious Disease Journal|July 30, 2024
The Retrospective Implementation of Standardized In Utero HIV Exposure Definitions Using Routinely Collected Public Sector Data Across the Western Cape Province, South AfricaShani T de Beer, Mary-Ann Davies, Florence Phelanyane, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2012
A phase I trial and pharmacokinetic study of aflibercept (VEGF Trap) in children with refractory solid tumors: a children's oncology group phase I consortium reportJulia Glade Bender, Susan M Blaney, Scott Borinstein, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2007
Phase I trial and pharmacokinetic study of pemetrexed in children with refractory solid tumors: the Children's Oncology GroupSuman Malempati, H Stacy Nicholson, Joel M Reid, et al.Clinical Oncology (Royal College of Radiologists (Great Britain))|November 6, 2022
Understanding the Benefit of Magnetic Resonance-guided Adaptive Radiotherapy in Rectal Cancer Patients: a Single-centre StudyM Ingle, I White, J Chick, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2007
Phase I pharmacokinetic and pharmacodynamic study of temozolomide in pediatric patients with refractory or recurrent leukemia: a Children's Oncology Group StudyTerzah M Horton, Patrick A Thompson, Stacey L Berg, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2013
Phase I pharmacokinetic and pharmacodynamic study of pazopanib in children with soft tissue sarcoma and other refractory solid tumors: a children's oncology group phase I consortium reportJulia L Glade Bender, Alice Lee, Joel M Reid, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 22, 2011
Phase I and pharmacokinetic study of sunitinib in pediatric patients with refractory solid tumors: a children's oncology group studySteven G Dubois, Suzanne Shusterman, Ashish M Ingle, et al.Pediatric Blood & Cancer|August 14, 2012
A phase I trial of vorinostat and bortezomib in children with refractory or recurrent solid tumors: a Children's Oncology Group phase I consortium study (ADVL0916)Jodi A Muscal, Patrick A Thompson, Terzah M Horton, et al.Journal of Pediatric Surgery|January 20, 2023
Outcomes of laparoscopic versus open resection of pediatric choledochal cystWalter A Ramsey, Carlos T Huerta, Shreya M Ingle, et al.AIDS (London, England)|November 27, 2014
Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North AmericaMarie Helleberg, Margaret T May, Suzanne M Ingle, et al.Pageof 11